Fingolimod Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fingolimod Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fingolimod Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 20 USDMF, 15 CEP/COS, 1 JDMF, 13 EU WC, 17 NDC API, 31 Listed Suppliers, $ API Reference Price

48 API Suppliers
20 USDMF
15 CEP/COS
1 JDMF
13 EU WC
17 NDC API
31 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers, 25 FDA Orange Book, 16 Europe, 10 Canada, 9 Australia, 2 South Africa, 10 Listed Dossiers

72 FDF Dossiers
25 FDA Orange Book
16 Europe
10 Canada
9 Australia
2 South Africa
10 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 6 DKSH, 2 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 3 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 2 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 5 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Vasa Pharmachem

1 Rochem International Inc
13 SPI Pharma
6 DKSH
2 Faran Shimi Pharmaceutical
1 Gangwal Healthcare
1 Pfanstiehl
4 ACG Worldwide
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
3 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
3 Lonza Capsugel
7 Microlex e.U
2 Pluviaendo
1 Prachin Chemical
1 Qualicaps
5 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

26 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 11 Taste Masking, 10 Direct Compression, 8 Lubricants & Glidants, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 6 Thickeners and Stabilizers, 5 Co-Processed Excipients, 5 Coating Systems & Additives, 4 Parenteral, 3 Granulation, 2 Film Formers & Plasticizers, 2 Coloring Agents, 1 Emulsifying Agents, 1 Solubilizers

26 Fillers, Diluents & Binders
11 Chewable & Orodispersible Aids
11 Taste Masking
10 Direct Compression
8 Lubricants & Glidants
8 Empty Capsules
7 Disintegrants & Superdisintegrants
6 Thickeners and Stabilizers
5 Co-Processed Excipients
5 Coating Systems & Additives
4 Parenteral
3 Granulation
2 Film Formers & Plasticizers
2 Coloring Agents
1 Emulsifying Agents
1 Solubilizers

DIGITAL CONTENT

143 NEWS #PharmaBuzz

143 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 13 Finished Drug Prices, 22 Annual Reports

2 US Medicaid Prescriptions
13 Finished Drug Prices
22 Annual Reports

MARKET PLACE

5 APIs, 8 FDF Dossiers

5 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

13 US Patents, 3 Health Canada Patents

13 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 13 Others

1 USP
13 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 140,532 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Gowling WLG (Canada) LLP

filter Patent Reset all filters

3 All

01 12126337

02 12521325

03 12653569

filter Product Reset all filters

3 All

01 3Fingolimod hydrochloride

filter Dosage Reset all filters

3 All

01 3Capsules

filter Exp Date Reset all filters

3 All

01 12013-10-18

02 12024-04-06

03 12027-06-25

Synnat Fingolimod Hydrochloride

Product Main Page

01

Gowling WLG (Canada) LLP

Fingolimod Hydrochloride

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-06

Date Granted : 2010-09-14

Fingolimod Hydrochloride

Brand Name : GILENYA

Patent Number : 2521325

Filing Date : 2004-04-06

Strength per Unit : 0.5 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-04-06

Date Granted : 2010-09-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Fingolimod Hydrochloride

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-10-18

Date Granted : 2003-06-24

Fingolimod Hydrochloride

Brand Name : GILENYA

Patent Number : 2126337

Filing Date : 1993-10-18

Strength per Unit : 0.5 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-10-18

Date Granted : 2003-06-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Fingolimod Hydrochloride

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-25

Date Granted : 2016-06-21

Fingolimod Hydrochloride

Brand Name : GILENYA

Patent Number : 2653569

Filing Date : 2007-06-25

Strength per Unit : 0.5 mg

Dosage Form : Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-06-25

Date Granted : 2016-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!